Arimidex
Arimidex is a medicine authorised by Swissmedic under authorisation number 53535. The authorisation holder is Medius AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 21 May 1996 and the authorisation is valid without a time limit. ATC code L02BG03 places the medicine in the group Endocrine therapy.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Arimidex, Filmtabletten | B | 21 May 1996 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 11 | 30 | Tablette(n) | L02BG03 | 07.16.2. | B |
| 38 | 100 | Tablette(n) | L02BG03 | 07.16.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Arimidex authorised in Switzerland?
Yes. Arimidex is authorised by Swissmedic under authorisation number 53535, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Arimidex have?
Arimidex is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Arimidex?
The authorisation holder is Medius AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.